ZA200200114B - Method for preparing substituted (1,4)diazepino(6,7,1-hi)indol-4-ones. - Google Patents

Method for preparing substituted (1,4)diazepino(6,7,1-hi)indol-4-ones. Download PDF

Info

Publication number: ZA200200114B
Authority: ZA; South Africa
Prior art keywords: alkyl; process according; hydrogen; zinc; scandium
Prior art date: 1999-07-02

Application number

ZA200200114A

Other languages

English (en)

Inventor

Patrick Bernardelli

Original Assignee

Warner Lambert Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-07-02

Filing date

2002-01-07

Publication date

2002-10-30

2002-01-07 Application filed by Warner Lambert Co filed Critical Warner Lambert Co

2002-10-30 Publication of ZA200200114B publication Critical patent/ZA200200114B/en

Links

238000000034 method Methods 0.000 title claims description 36
RTDDGJVVKVRATF-UHFFFAOYSA-N 1,10-diazatricyclo[6.4.1.04,13]trideca-2,4(13),5,7,9-pentaen-12-one Chemical class O=C1CN=Cc2cccc3ccn1c23 RTDDGJVVKVRATF-UHFFFAOYSA-N 0.000 title 1
125000000217 alkyl group Chemical group 0.000 claims description 36
229910052739 hydrogen Inorganic materials 0.000 claims description 27
239000001257 hydrogen Substances 0.000 claims description 26
239000002841 Lewis acid Substances 0.000 claims description 18
150000007517 lewis acids Chemical class 0.000 claims description 18
150000002431 hydrogen Chemical class 0.000 claims description 16
-1 mercury (II) halides Chemical class 0.000 claims description 12
238000002360 preparation method Methods 0.000 claims description 12
XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 10
HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 10
229910052725 zinc Inorganic materials 0.000 claims description 10
239000011701 zinc Substances 0.000 claims description 10
XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims description 9
229910052710 silicon Inorganic materials 0.000 claims description 9
239000010703 silicon Substances 0.000 claims description 9
ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 claims description 8
125000003545 alkoxy group Chemical group 0.000 claims description 8
229910052796 boron Inorganic materials 0.000 claims description 8
150000001875 compounds Chemical class 0.000 claims description 8
GYHNNYVSQQEPJS-UHFFFAOYSA-N Gallium Chemical compound [Ga] GYHNNYVSQQEPJS-UHFFFAOYSA-N 0.000 claims description 7
239000004411 aluminium Substances 0.000 claims description 7
229910052782 aluminium Inorganic materials 0.000 claims description 7
XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims description 7
229910052733 gallium Inorganic materials 0.000 claims description 7
229910052747 lanthanoid Inorganic materials 0.000 claims description 7
150000002602 lanthanoids Chemical class 0.000 claims description 7
239000003446 ligand Substances 0.000 claims description 7
229910052706 scandium Inorganic materials 0.000 claims description 7
SIXSYDAISGFNSX-UHFFFAOYSA-N scandium atom Chemical compound [Sc] SIXSYDAISGFNSX-UHFFFAOYSA-N 0.000 claims description 7
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 6
FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 6
ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 claims description 6
RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 claims description 6
229910052787 antimony Inorganic materials 0.000 claims description 6
WATWJIUSRGPENY-UHFFFAOYSA-N antimony atom Chemical compound [Sb] WATWJIUSRGPENY-UHFFFAOYSA-N 0.000 claims description 6
229910052799 carbon Inorganic materials 0.000 claims description 6
229910052736 halogen Inorganic materials 0.000 claims description 6
150000002367 halogens Chemical class 0.000 claims description 6
229910052749 magnesium Inorganic materials 0.000 claims description 6
239000011777 magnesium Substances 0.000 claims description 6
239000011135 tin Substances 0.000 claims description 6
229910052718 tin Inorganic materials 0.000 claims description 6
229910052719 titanium Inorganic materials 0.000 claims description 6
239000010936 titanium Substances 0.000 claims description 6
BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims description 5
239000011575 calcium Substances 0.000 claims description 5
125000004432 carbon atom Chemical group C* 0.000 claims description 5
229910052742 iron Inorganic materials 0.000 claims description 5
125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 5
HZXJVDYQRYYYOR-UHFFFAOYSA-K scandium(iii) trifluoromethanesulfonate Chemical compound [Sc+3].[O-]S(=O)(=O)C(F)(F)F.[O-]S(=O)(=O)C(F)(F)F.[O-]S(=O)(=O)C(F)(F)F HZXJVDYQRYYYOR-UHFFFAOYSA-K 0.000 claims description 5
229910052709 silver Inorganic materials 0.000 claims description 5
239000004332 silver Substances 0.000 claims description 5
ZWOMUDQWODQGQH-UHFFFAOYSA-N 1H-pyrrolo[2,3-g][1,2]benzodiazepin-2-one Chemical compound C1=CC2=NN=CC=CC2=C2C1=CC(=O)N2 ZWOMUDQWODQGQH-UHFFFAOYSA-N 0.000 claims description 4
PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 claims description 4
125000004093 cyano group Chemical group *C#N 0.000 claims description 4
125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 4
125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 4
229910052738 indium Inorganic materials 0.000 claims description 4
APFVFJFRJDLVQX-UHFFFAOYSA-N indium atom Chemical compound [In] APFVFJFRJDLVQX-UHFFFAOYSA-N 0.000 claims description 4
125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 claims description 4
239000011968 lewis acid catalyst Substances 0.000 claims description 3
230000007935 neutral effect Effects 0.000 claims description 3
229910052757 nitrogen Inorganic materials 0.000 claims description 3
150000003839 salts Chemical class 0.000 claims description 3
IUTCEZPPWBHGIX-UHFFFAOYSA-N tin(2+) Chemical compound [Sn+2] IUTCEZPPWBHGIX-UHFFFAOYSA-N 0.000 claims description 3
125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 claims description 2
CICHFENMQCHERI-UHFFFAOYSA-N C=1C=CCC=1[Ti](OC)(OC)C1=CC=CC1 Chemical compound C=1C=CCC=1[Ti](OC)(OC)C1=CC=CC1 CICHFENMQCHERI-UHFFFAOYSA-N 0.000 claims description 2
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 2
RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 2
JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 claims description 2
QCWXUUIWCKQGHC-UHFFFAOYSA-N Zirconium Chemical compound [Zr] QCWXUUIWCKQGHC-UHFFFAOYSA-N 0.000 claims description 2
150000001408 amides Chemical class 0.000 claims description 2
125000000129 anionic group Chemical group 0.000 claims description 2
125000004429 atom Chemical group 0.000 claims description 2
125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 2
FKOASGGZYSYPBI-UHFFFAOYSA-K bis(trifluoromethylsulfonyloxy)alumanyl trifluoromethanesulfonate Chemical compound [Al+3].[O-]S(=O)(=O)C(F)(F)F.[O-]S(=O)(=O)C(F)(F)F.[O-]S(=O)(=O)C(F)(F)F FKOASGGZYSYPBI-UHFFFAOYSA-K 0.000 claims description 2
FPCJKVGGYOAWIZ-UHFFFAOYSA-N butan-1-ol;titanium Chemical compound [Ti].CCCCO.CCCCO.CCCCO.CCCCO FPCJKVGGYOAWIZ-UHFFFAOYSA-N 0.000 claims description 2
229910052791 calcium Inorganic materials 0.000 claims description 2
229910017052 cobalt Inorganic materials 0.000 claims description 2
239000010941 cobalt Substances 0.000 claims description 2
GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 claims description 2
229910052802 copper Inorganic materials 0.000 claims description 2
239000010949 copper Substances 0.000 claims description 2
PESYEWKSBIWTAK-UHFFFAOYSA-N cyclopenta-1,3-diene;titanium(2+) Chemical compound [Ti+2].C=1C=C[CH-]C=1.C=1C=C[CH-]C=1 PESYEWKSBIWTAK-UHFFFAOYSA-N 0.000 claims description 2
HQWPLXHWEZZGKY-UHFFFAOYSA-N diethylzinc Chemical compound CC[Zn]CC HQWPLXHWEZZGKY-UHFFFAOYSA-N 0.000 claims description 2
150000002148 esters Chemical class 0.000 claims description 2
229910052746 lanthanum Inorganic materials 0.000 claims description 2
FZLIPJUXYLNCLC-UHFFFAOYSA-N lanthanum atom Chemical compound [La] FZLIPJUXYLNCLC-UHFFFAOYSA-N 0.000 claims description 2
CRGZYKWWYNQGEC-UHFFFAOYSA-N magnesium;methanolate Chemical compound [Mg+2].[O-]C.[O-]C CRGZYKWWYNQGEC-UHFFFAOYSA-N 0.000 claims description 2
WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 claims description 2
QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 claims description 2
229910052753 mercury Inorganic materials 0.000 claims description 2
229910052751 metal Inorganic materials 0.000 claims description 2
239000002184 metal Substances 0.000 claims description 2
229910052759 nickel Inorganic materials 0.000 claims description 2
125000004433 nitrogen atom Chemical group N* 0.000 claims description 2
239000000651 prodrug Substances 0.000 claims description 2
229940002612 prodrug Drugs 0.000 claims description 2
QRUBYZBWAOOHSV-UHFFFAOYSA-M silver trifluoromethanesulfonate Chemical class [Ag+].[O-]S(=O)(=O)C(F)(F)F QRUBYZBWAOOHSV-UHFFFAOYSA-M 0.000 claims description 2
239000012453 solvate Substances 0.000 claims description 2
AFCAKJKUYFLYFK-UHFFFAOYSA-N tetrabutyltin Chemical compound CCCC[Sn](CCCC)(CCCC)CCCC AFCAKJKUYFLYFK-UHFFFAOYSA-N 0.000 claims description 2
229910052716 thallium Inorganic materials 0.000 claims description 2
BKVIYDNLLOSFOA-UHFFFAOYSA-N thallium Chemical compound [Tl] BKVIYDNLLOSFOA-UHFFFAOYSA-N 0.000 claims description 2
VXUYXOFXAQZZMF-UHFFFAOYSA-N titanium(IV) isopropoxide Chemical compound CC(C)O[Ti](OC(C)C)(OC(C)C)OC(C)C VXUYXOFXAQZZMF-UHFFFAOYSA-N 0.000 claims description 2
229910052723 transition metal Inorganic materials 0.000 claims description 2
150000003624 transition metals Chemical class 0.000 claims description 2
VOITXYVAKOUIBA-UHFFFAOYSA-N triethylaluminium Chemical compound CC[Al](CC)CC VOITXYVAKOUIBA-UHFFFAOYSA-N 0.000 claims description 2
ITMCEJHCFYSIIV-UHFFFAOYSA-M triflate Chemical compound [O-]S(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-M 0.000 claims description 2
MCULRUJILOGHCJ-UHFFFAOYSA-N triisobutylaluminium Chemical compound CC(C)C[Al](CC(C)C)CC(C)C MCULRUJILOGHCJ-UHFFFAOYSA-N 0.000 claims description 2
WXRGABKACDFXMG-UHFFFAOYSA-N trimethylborane Chemical compound CB(C)C WXRGABKACDFXMG-UHFFFAOYSA-N 0.000 claims description 2
MXSVLWZRHLXFKH-UHFFFAOYSA-N triphenylborane Chemical compound C1=CC=CC=C1B(C=1C=CC=CC=1)C1=CC=CC=C1 MXSVLWZRHLXFKH-UHFFFAOYSA-N 0.000 claims description 2
HVYVMSPIJIWUNA-UHFFFAOYSA-N triphenylstibine Chemical compound C1=CC=CC=C1[Sb](C=1C=CC=CC=1)C1=CC=CC=C1 HVYVMSPIJIWUNA-UHFFFAOYSA-N 0.000 claims description 2
229910052727 yttrium Inorganic materials 0.000 claims description 2
VWQVUPCCIRVNHF-UHFFFAOYSA-N yttrium atom Chemical compound [Y] VWQVUPCCIRVNHF-UHFFFAOYSA-N 0.000 claims description 2
DJWUNCQRNNEAKC-UHFFFAOYSA-L zinc acetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O DJWUNCQRNNEAKC-UHFFFAOYSA-L 0.000 claims description 2
235000013904 zinc acetate Nutrition 0.000 claims description 2
239000004246 zinc acetate Substances 0.000 claims description 2
NHXVNEDMKGDNPR-UHFFFAOYSA-N zinc;pentane-2,4-dione Chemical compound [Zn+2].CC(=O)[CH-]C(C)=O.CC(=O)[CH-]C(C)=O NHXVNEDMKGDNPR-UHFFFAOYSA-N 0.000 claims description 2
229910052726 zirconium Inorganic materials 0.000 claims description 2
VTLYFUHAOXGGBS-UHFFFAOYSA-N Fe3+ Chemical compound [Fe+3] VTLYFUHAOXGGBS-UHFFFAOYSA-N 0.000 claims 1
238000003402 intramolecular cyclocondensation reaction Methods 0.000 claims 1
239000000543 intermediate Substances 0.000 description 30
YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 12
238000006243 chemical reaction Methods 0.000 description 10
239000000047 product Substances 0.000 description 10
239000002904 solvent Substances 0.000 description 10
RWZYAGGXGHYGMB-UHFFFAOYSA-N anthranilic acid Chemical class NC1=CC=CC=C1C(O)=O RWZYAGGXGHYGMB-UHFFFAOYSA-N 0.000 description 9
150000003254 radicals Chemical class 0.000 description 8
ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 7
NDNQCTVYOKEYIV-UHFFFAOYSA-N 1h-1,2-benzodiazepin-3-amine Chemical class C1=CC(N)=NNC2=CC=CC=C21 NDNQCTVYOKEYIV-UHFFFAOYSA-N 0.000 description 6
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
239000002253 acid Substances 0.000 description 6
125000003277 amino group Chemical group 0.000 description 5
239000000203 mixture Substances 0.000 description 5
QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 4
WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
238000006722 reduction reaction Methods 0.000 description 4
238000007363 ring formation reaction Methods 0.000 description 4
HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 3
UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 description 3
YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
150000001412 amines Chemical class 0.000 description 3
239000003054 catalyst Substances 0.000 description 3
239000007822 coupling agent Substances 0.000 description 3
VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 3
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 3
125000006239 protecting group Chemical group 0.000 description 3
230000009467 reduction Effects 0.000 description 3
239000000126 substance Substances 0.000 description 3
RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 2
CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 2
IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 2
OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 2
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
230000015572 biosynthetic process Effects 0.000 description 2
150000008280 chlorinated hydrocarbons Chemical class 0.000 description 2
MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 2
229960001701 chloroform Drugs 0.000 description 2
230000008878 coupling Effects 0.000 description 2
238000010168 coupling process Methods 0.000 description 2
238000005859 coupling reaction Methods 0.000 description 2
150000004292 cyclic ethers Chemical class 0.000 description 2
125000000753 cycloalkyl group Chemical group 0.000 description 2
239000003814 drug Substances 0.000 description 2
ZSWFCLXCOIISFI-UHFFFAOYSA-N endo-cyclopentadiene Natural products C1C=CC=C1 ZSWFCLXCOIISFI-UHFFFAOYSA-N 0.000 description 2
150000004820 halides Chemical class 0.000 description 2
238000004128 high performance liquid chromatography Methods 0.000 description 2
150000005627 indol-4-ones Chemical class 0.000 description 2
239000003112 inhibitor Substances 0.000 description 2
BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
RMCDUNHIVVEEDD-UHFFFAOYSA-N methylcyclopropane Chemical compound [CH2]C1CC1 RMCDUNHIVVEEDD-UHFFFAOYSA-N 0.000 description 2
LQNUZADURLCDLV-UHFFFAOYSA-N nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1 LQNUZADURLCDLV-UHFFFAOYSA-N 0.000 description 2
150000002891 organic anions Chemical class 0.000 description 2
150000002905 orthoesters Chemical class 0.000 description 2
239000001301 oxygen Substances 0.000 description 2
229910052760 oxygen Inorganic materials 0.000 description 2
150000003141 primary amines Chemical group 0.000 description 2
239000000376 reactant Substances 0.000 description 2
239000007858 starting material Substances 0.000 description 2
238000003786 synthesis reaction Methods 0.000 description 2
YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
HDPNBNXLBDFELL-UHFFFAOYSA-N 1,1,1-trimethoxyethane Chemical compound COC(C)(OC)OC HDPNBNXLBDFELL-UHFFFAOYSA-N 0.000 description 1
ASOKPJOREAFHNY-UHFFFAOYSA-N 1-Hydroxybenzotriazole Chemical compound C1=CC=C2N(O)N=NC2=C1 ASOKPJOREAFHNY-UHFFFAOYSA-N 0.000 description 1
SVUOLADPCWQTTE-UHFFFAOYSA-N 1h-1,2-benzodiazepine Chemical compound N1N=CC=CC2=CC=CC=C12 SVUOLADPCWQTTE-UHFFFAOYSA-N 0.000 description 1
BYGHHEDJDSLEKK-UHFFFAOYSA-N 2-[(2-methylpropan-2-yl)oxycarbonylamino]benzoic acid Chemical compound CC(C)(C)OC(=O)NC1=CC=CC=C1C(O)=O BYGHHEDJDSLEKK-UHFFFAOYSA-N 0.000 description 1
YOETUEMZNOLGDB-UHFFFAOYSA-N 2-methylpropyl carbonochloridate Chemical compound CC(C)COC(Cl)=O YOETUEMZNOLGDB-UHFFFAOYSA-N 0.000 description 1
JMTMSDXUXJISAY-UHFFFAOYSA-N 2H-benzotriazol-4-ol Chemical compound OC1=CC=CC2=C1N=NN2 JMTMSDXUXJISAY-UHFFFAOYSA-N 0.000 description 1
OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 1
102000004190 Enzymes Human genes 0.000 description 1
108090000790 Enzymes Proteins 0.000 description 1
PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
238000005727 Friedel-Crafts reaction Methods 0.000 description 1
229910021578 Iron(III) chloride Inorganic materials 0.000 description 1
230000006181 N-acylation Effects 0.000 description 1
229910019142 PO4 Inorganic materials 0.000 description 1
102000004861 Phosphoric Diester Hydrolases Human genes 0.000 description 1
108090001050 Phosphoric Diester Hydrolases Proteins 0.000 description 1
QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
LCKIEQZJEYYRIY-UHFFFAOYSA-N Titanium ion Chemical compound [Ti+4] LCKIEQZJEYYRIY-UHFFFAOYSA-N 0.000 description 1
229910052769 Ytterbium Inorganic materials 0.000 description 1
TXTQARDVRPFFHL-UHFFFAOYSA-N [Sb].[H][H] Chemical compound [Sb].[H][H] TXTQARDVRPFFHL-UHFFFAOYSA-N 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
150000001338 aliphatic hydrocarbons Chemical class 0.000 description 1
230000003266 anti-allergic effect Effects 0.000 description 1
230000001088 anti-asthma Effects 0.000 description 1
239000002260 anti-inflammatory agent Substances 0.000 description 1
229940121363 anti-inflammatory agent Drugs 0.000 description 1
230000003110 anti-inflammatory effect Effects 0.000 description 1
239000000043 antiallergic agent Substances 0.000 description 1
239000000924 antiasthmatic agent Substances 0.000 description 1
150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
JXLHNMVSKXFWAO-UHFFFAOYSA-N azane;7-fluoro-2,1,3-benzoxadiazole-4-sulfonic acid Chemical compound N.OS(=O)(=O)C1=CC=C(F)C2=NON=C12 JXLHNMVSKXFWAO-UHFFFAOYSA-N 0.000 description 1
229940049706 benzodiazepine Drugs 0.000 description 1
125000003310 benzodiazepinyl group Chemical class N1N=C(C=CC2=C1C=CC=C2)* 0.000 description 1
GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
229910052794 bromium Inorganic materials 0.000 description 1
150000001649 bromium compounds Chemical class 0.000 description 1
229940124630 bronchodilator Drugs 0.000 description 1
239000000168 bronchodilator agent Substances 0.000 description 1
150000001718 carbodiimides Chemical class 0.000 description 1
150000001721 carbon Chemical group 0.000 description 1
229950005499 carbon tetrachloride Drugs 0.000 description 1
PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 1
230000003197 catalytic effect Effects 0.000 description 1
238000010531 catalytic reduction reaction Methods 0.000 description 1
239000007795 chemical reaction product Substances 0.000 description 1
239000003153 chemical reaction reagent Substances 0.000 description 1
229910052801 chlorine Inorganic materials 0.000 description 1
239000000460 chlorine Substances 0.000 description 1
238000004587 chromatography analysis Methods 0.000 description 1
238000009833 condensation Methods 0.000 description 1
230000005494 condensation Effects 0.000 description 1
125000000058 cyclopentadienyl group Chemical group C1(=CC=CC1)* 0.000 description 1
239000012024 dehydrating agents‎ Substances 0.000 description 1
150000001983 dialkylethers Chemical class 0.000 description 1
229960001760 dimethyl sulfoxide Drugs 0.000 description 1
230000000694 effects Effects 0.000 description 1
238000005516 engineering process Methods 0.000 description 1
125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
238000002474 experimental method Methods 0.000 description 1
239000012467 final product Substances 0.000 description 1
229910052731 fluorine Inorganic materials 0.000 description 1
239000011737 fluorine Substances 0.000 description 1
235000019253 formic acid Nutrition 0.000 description 1
238000005984 hydrogenation reaction Methods 0.000 description 1
230000007062 hydrolysis Effects 0.000 description 1
238000006460 hydrolysis reaction Methods 0.000 description 1
NPZTUJOABDZTLV-UHFFFAOYSA-N hydroxybenzotriazole Substances O=C1C=CC=C2NNN=C12 NPZTUJOABDZTLV-UHFFFAOYSA-N 0.000 description 1
239000012442 inert solvent Substances 0.000 description 1
229910052740 iodine Inorganic materials 0.000 description 1
239000011630 iodine Substances 0.000 description 1
RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 1
AQBLLJNPHDIAPN-LNTINUHCSA-K iron(3+);(z)-4-oxopent-2-en-2-olate Chemical compound [Fe+3].C\C([O-])=C\C(C)=O.C\C([O-])=C\C(C)=O.C\C([O-])=C\C(C)=O AQBLLJNPHDIAPN-LNTINUHCSA-K 0.000 description 1
239000011967 lanthanide triflate Substances 0.000 description 1
150000002680 magnesium Chemical class 0.000 description 1
229910052943 magnesium sulfate Inorganic materials 0.000 description 1
235000019341 magnesium sulphate Nutrition 0.000 description 1
LWJROJCJINYWOX-UHFFFAOYSA-L mercury dichloride Chemical class Cl[Hg]Cl LWJROJCJINYWOX-UHFFFAOYSA-L 0.000 description 1
NCPHGZWGGANCAY-UHFFFAOYSA-N methane;ruthenium Chemical compound C.[Ru] NCPHGZWGGANCAY-UHFFFAOYSA-N 0.000 description 1
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
150000007522 mineralic acids Chemical class 0.000 description 1
239000002808 molecular sieve Substances 0.000 description 1
230000003287 optical effect Effects 0.000 description 1
150000007524 organic acids Chemical class 0.000 description 1
150000007530 organic bases Chemical class 0.000 description 1
239000003960 organic solvent Substances 0.000 description 1
QIIPQYDSKRYMFG-UHFFFAOYSA-N phenyl hydrogen carbonate Chemical compound OC(=O)OC1=CC=CC=C1 QIIPQYDSKRYMFG-UHFFFAOYSA-N 0.000 description 1
125000003884 phenylalkyl group Chemical group 0.000 description 1
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
239000010452 phosphate Substances 0.000 description 1
UEZVMMHDMIWARA-UHFFFAOYSA-M phosphonate Chemical compound [O-]P(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-M 0.000 description 1
239000003880 polar aprotic solvent Substances 0.000 description 1
UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
229910052761 rare earth metal Inorganic materials 0.000 description 1
239000011541 reaction mixture Substances 0.000 description 1
238000012552 review Methods 0.000 description 1
URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
125000000547 substituted alkyl group Chemical group 0.000 description 1
229910021653 sulphate ion Inorganic materials 0.000 description 1
VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 1
238000002560 therapeutic procedure Methods 0.000 description 1
HPGGPRDJHPYFRM-UHFFFAOYSA-J tin(iv) chloride Chemical compound Cl[Sn](Cl)(Cl)Cl HPGGPRDJHPYFRM-UHFFFAOYSA-J 0.000 description 1
XJDNKRIXUMDJCW-UHFFFAOYSA-J titanium tetrachloride Chemical compound Cl[Ti](Cl)(Cl)Cl XJDNKRIXUMDJCW-UHFFFAOYSA-J 0.000 description 1
CMWCOKOTCLFJOP-UHFFFAOYSA-N titanium(3+) Chemical compound [Ti+3] CMWCOKOTCLFJOP-UHFFFAOYSA-N 0.000 description 1
238000005292 vacuum distillation Methods 0.000 description 1
NAWDYIZEMPQZHO-UHFFFAOYSA-N ytterbium Chemical compound [Yb] NAWDYIZEMPQZHO-UHFFFAOYSA-N 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/06—Peri-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

ZA200200114A 1999-07-02 2002-01-07 Method for preparing substituted (1,4)diazepino(6,7,1-hi)indol-4-ones. ZA200200114B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR9908537A FR2795731B1 (fr)	1999-07-02	1999-07-02	PROCEDE DE PREPARATION DE [1,4] DIAZEPINO [6,7,1-hi] INDOL-4-ONES SUBSTITUEES

Publications (1)

Publication Number	Publication Date
ZA200200114B true ZA200200114B (en)	2002-10-30

Family

ID=9547630

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA200200114A ZA200200114B (en)	1999-07-02	2002-01-07	Method for preparing substituted (1,4)diazepino(6,7,1-hi)indol-4-ones.

Country Status (31)

Country	Link
US (1)	US6689881B1 (et)
EP (1)	EP1196418B1 (et)
JP (1)	JP2003503498A (et)
KR (1)	KR20020016644A (et)
CN (1)	CN1166668C (et)
AP (1)	AP2001002378A0 (et)
AT (1)	ATE269334T1 (et)
AU (1)	AU772966B2 (et)
BG (1)	BG106264A (et)
BR (1)	BR0012532A (et)
CA (1)	CA2376707A1 (et)
CZ (1)	CZ20014681A3 (et)
DE (1)	DE60011619D1 (et)
DZ (1)	DZ3260A1 (et)
EA (1)	EA004675B1 (et)
EE (1)	EE200100700A (et)
FR (1)	FR2795731B1 (et)
HR (1)	HRP20010952A2 (et)
HU (1)	HUP0201635A3 (et)
IL (1)	IL147364A0 (et)
IS (1)	IS6211A (et)
MX (1)	MXPA02000257A (et)
NO (1)	NO20016271L (et)
NZ (1)	NZ516287A (et)
OA (1)	OA11981A (et)
PL (1)	PL357075A1 (et)
SK (1)	SK19242001A3 (et)
TR (1)	TR200103857T2 (et)
WO (1)	WO2001002403A1 (et)
YU (1)	YU92001A (et)
ZA (1)	ZA200200114B (et)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2578561A1 (en)	2005-09-29	2013-04-10	Albany Molecular Research, Inc.	Processes for the production of cannabidiol derivatives and intermediates thereof
US12029718B2 (en)	2021-11-09	2024-07-09	Cct Sciences, Llc	Process for production of essentially pure delta-9-tetrahydrocannabinol

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5256801A (en)	1992-08-14	1993-10-26	Napro Biotherapeutics, Inc.	Processes of converting taxanes into 10-deacetylbaccatin III
US5342971A (en)	1992-12-29	1994-08-30	The Australian National University	Process for the preparation of dibenzo[b,d]pyrans
GB9305806D0 (en)	1993-03-20	1993-05-05	Glaxo Spa	Chemical compounds
FR2762841B1 (fr) *	1997-04-30	1999-07-02	Jouveinal Inst Rech	Diazepino-indolones inhibitrices de phosphodiesterases iv

1999
- 1999-07-02 FR FR9908537A patent/FR2795731B1/fr not_active Expired - Fee Related
2000
- 2000-06-29 TR TR2001/03857T patent/TR200103857T2/xx unknown
- 2000-06-29 PL PL00357075A patent/PL357075A1/xx not_active Application Discontinuation
- 2000-06-29 IL IL14736400A patent/IL147364A0/xx unknown
- 2000-06-29 HU HU0201635A patent/HUP0201635A3/hu unknown
- 2000-06-29 NZ NZ516287A patent/NZ516287A/xx unknown
- 2000-06-29 CN CNB008107076A patent/CN1166668C/zh not_active Expired - Fee Related
- 2000-06-29 DE DE60011619T patent/DE60011619D1/de not_active Expired - Fee Related
- 2000-06-29 WO PCT/FR2000/001839 patent/WO2001002403A1/fr not_active Ceased
- 2000-06-29 CZ CZ20014681A patent/CZ20014681A3/cs unknown
- 2000-06-29 KR KR1020017016967A patent/KR20020016644A/ko not_active Withdrawn
- 2000-06-29 HR HR20010952A patent/HRP20010952A2/xx not_active Application Discontinuation
- 2000-06-29 YU YU92001A patent/YU92001A/sh unknown
- 2000-06-29 OA OA1200100349A patent/OA11981A/fr unknown
- 2000-06-29 EE EEP200100700A patent/EE200100700A/et unknown
- 2000-06-29 US US10/019,191 patent/US6689881B1/en not_active Expired - Fee Related
- 2000-06-29 AU AU62896/00A patent/AU772966B2/en not_active Ceased
- 2000-06-29 JP JP2001507839A patent/JP2003503498A/ja active Pending
- 2000-06-29 SK SK1924-2001A patent/SK19242001A3/sk unknown
- 2000-06-29 BR BR0012532-6A patent/BR0012532A/pt not_active IP Right Cessation
- 2000-06-29 AP APAP/P/2001/002378A patent/AP2001002378A0/en unknown
- 2000-06-29 EP EP00949588A patent/EP1196418B1/fr not_active Expired - Lifetime
- 2000-06-29 DZ DZ003260A patent/DZ3260A1/fr active
- 2000-06-29 AT AT00949588T patent/ATE269334T1/de not_active IP Right Cessation
- 2000-06-29 EA EA200101235A patent/EA004675B1/ru not_active IP Right Cessation
- 2000-06-29 CA CA002376707A patent/CA2376707A1/en not_active Abandoned
- 2000-06-29 MX MXPA02000257A patent/MXPA02000257A/es unknown
2001
- 2001-12-20 NO NO20016271A patent/NO20016271L/no not_active Application Discontinuation
- 2001-12-21 IS IS6211A patent/IS6211A/is unknown
- 2001-12-21 BG BG106264A patent/BG106264A/xx unknown
2002
- 2002-01-07 ZA ZA200200114A patent/ZA200200114B/en unknown

Also Published As

Publication number	Publication date
HUP0201635A3 (en)	2004-12-28
EA200101235A1 (ru)	2002-06-27
MXPA02000257A (es)	2003-08-20
NO20016271L (no)	2001-12-28
CN1362960A (zh)	2002-08-07
OA11981A (fr)	2006-04-17
TR200103857T2 (tr)	2003-01-21
DE60011619D1 (de)	2004-07-22
CA2376707A1 (en)	2001-01-11
US6689881B1 (en)	2004-02-10
EA004675B1 (ru)	2004-06-24
IL147364A0 (en)	2002-08-14
EE200100700A (et)	2003-04-15
CZ20014681A3 (cs)	2002-08-14
AP2001002378A0 (en)	2001-12-31
FR2795731B1 (fr)	2001-09-07
EP1196418A1 (fr)	2002-04-17
BR0012532A (pt)	2002-04-02
NZ516287A (en)	2003-06-30
HUP0201635A2 (en)	2002-09-28
NO20016271D0 (no)	2001-12-20
FR2795731A1 (fr)	2001-01-05
JP2003503498A (ja)	2003-01-28
ATE269334T1 (de)	2004-07-15
BG106264A (en)	2002-08-30
CN1166668C (zh)	2004-09-15
WO2001002403A1 (fr)	2001-01-11
IS6211A (is)	2001-12-21
AU772966B2 (en)	2004-05-13
HRP20010952A2 (en)	2003-06-30
KR20020016644A (ko)	2002-03-04
AU6289600A (en)	2001-01-22
YU92001A (sh)	2004-09-03
DZ3260A1 (fr)	2001-01-11
SK19242001A3 (sk)	2002-11-06
PL357075A1 (en)	2004-07-12
EP1196418B1 (fr)	2004-06-16

Publication	Publication Date	Title
Becker et al.	1996	A new ligand class for the asymmetric dihydroxylation of olefins
ZA200601055B (en)	2008-07-30	Regioselective synthesis of CCI-779
US6384278B1 (en)	2002-05-07	Boron-mediated amidation of carboxylic acids
Bravo et al.	1999	Asymmetric synthesis of α-arylglycinols via additions of lithium methyl p-tolyl sulfoxide to N-(PMP) arylaldimines followed by “non oxidative” Pummerer reaction
CN101563312A (zh)	2009-10-21	阿塞那平合成中间体的制备方法
US5554753A (en)	1996-09-10	Catalytic enantioselective synthesis of α-amino acid derivatives by phase-transfer catalysis
US9321794B2 (en)	2016-04-26	Synthesis of racemic amphetamine derivatives by cuprate addition reaction with aziridine phosphoramidate compounds
ZA200200114B (en)	2002-10-30	Method for preparing substituted (1,4)diazepino(6,7,1-hi)indol-4-ones.
EP0657415A1 (en)	1995-06-14	Optically active amino alcohol derivative and process for producing the same
US7863443B2 (en)	2011-01-04	Phosphoramidite ligand and production method of allylic amine using the same
WO2015130660A1 (en)	2015-09-03	Synthesis of racemic amphetamine derivatives by cuprate addition reaction with aziridine phosphoramidate compounds
CA2838971C (en)	2019-07-30	Production method of imidazole derivatives
JPH0334982A (ja)	1991-02-14	セファロスポリン化合物の還元
CN113773323B (zh)	2023-05-12	3r-氨基取代丁酰胺衍生物的制备方法
KR100272287B1 (ko)	2000-11-15	아세클로페낙의 신규 제조방법
CN106966940B (zh)	2019-03-19	一种西他列汀磷酸盐中间体n-芳甲基-2s-氰基甲基吖啶的制备方法
AU2021294219B2 (en)	2024-05-30	Process for making hydroxylated cyclopentylpyrimidine compounds
US9067868B2 (en)	2015-06-30	Chemical process for opening ring compounds
JP4374088B2 (ja)	2009-12-02	新規な４，４−ジフルオロベンゾアゼピンケタール誘導体、およびそれを経由する４，４−ジフルオロベンゾアゼピン−５−オン誘導体の製造方法
Hammond et al.	1991	New synthesis of 1-azabicyclo [5.3. 0] decane
CN113816955A (zh)	2021-12-21	一种ret激酶抑制剂中间体及其制备方法
WO2002081451A1 (en)	2002-10-17	Method for preparing 7-quinolinyl-3,5-dihydroxyhept-6-enoate
JP4166266B2 (ja)	2008-10-15	置換芳香族化合物の製造法および製造中間体
JP2002531571A (ja)	2002-09-24	ペニシラン酸スルホキシドエステルの製造方法
JPS6317869A (ja)	1988-01-25	２−低級アルキル−４−アミノ−５−ホルミルピリミジンの製造法